Current Status and Future Challenges of Liquid Biopsy—2nd Edition
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 1 October 2027 | Viewed by 1181
Special Issue Editors
2. Izumi City General Hospital, Izumi, Japan
Interests: minimal residual disease (MRD); surgical treatment for NSCLC; neoadjuvant and adjuvant treatment; immunotherapy; molecular targeted therapy; EGFR mutation; biomarker analysis
Special Issues, Collections and Topics in MDPI journals
Interests: minimal residual disease (MRD); surgical treatment for NSCLC; biomarker analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Clinical testing using liquid biopsy technology has been widely used in clinical practice for treating cancer patients, and the scope of its use is further expanding. Liquid biopsy is useful for detecting genetic aberrations and/or tumor mutation burden as a less invasive alternative to tissue biopsy. In addition, liquid biopsy has gained significant attention as a promising tool for minimal residual disease (MRD) detection after curative-intent treatment.
In this Special Issue, we will publish current status, limitations, technological developments, and future perspectives related to liquid biopsy for cancer patients from various perspectives, including basic research, translational data, clinical observations and clinical trials, as well as comprehensive reviews that focus on liquid biopsy. Educational case series related to liquid biopsy are also welcome.
This Special Issue will cover all aspects of studies related to liquid biopsy for cancer patients, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), circulating cell-free RNA, extracellular vesicles, and tumor-educated platelet (TEP). We invite all scientists working in the field of liquid biopsy to participate in this Special Issue.
Dr. Kenichi Suda
Dr. Shuta Ohara
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- minimal residual disease (MRD)
- ctDNA
- cfDNA
- heterogeneity
- comprehensive genomic profiling
- biomarker
- diagnosis
- personalization
- prognostic marker
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
